Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes

W. Bayer; R. Lietz; T. Ontikatze; L. Johrden; M. Tenbusch; G. Nabi; S. Schimmer; P. Groitl; H. Wolf; C.M. Berry; K. Überla; U. Dittmer; O. Wildner

doi:10.1186/1742-4690-8-75

Back

Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes

Journal article

Open access

Peer reviewed

Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes

W. Bayer, R. Lietz, T. Ontikatze, L. Johrden, M. Tenbusch, G. Nabi, S. Schimmer, P. Groitl, H. Wolf, C.M. Berry, …

Retrovirology, Vol.8(1)

2011

DOI: https://doi.org/10.1186/1742-4690-8-75

Files and links (2)

pdf

vaccine_protection_against_retrovirus_infection.pdfDownload View

Published (Version of Record)CC BY-NC V4.0, Open Access

url

Free to Read *No subscription requiredView

Abstract

Background Type I interferons (IFNs) exhibit direct antiviral effects, but also distinct immunomodulatory properties. In this study, we analyzed type I IFN subtypes for their effect on prophylactic adenovirus-based anti-retroviral vaccination of mice against Friend retrovirus (FV) or HIV. Results Mice were vaccinated with adenoviral vectors encoding FV Env and Gag proteins alone or in combination with vectors encoding IFNα1, IFNα2, IFNα4, IFNα5, IFNα6, IFNα9 or IFNβ. Only the co-administration of adenoviral vectors encoding IFNα2, IFNα4, IFNα6 and IFNα9 resulted in strongly improved immune protection of vaccinated mice from subsequent FV challenge infection with high control over FV-induced splenomegaly and reduced viral loads. The level of protection correlated with augmented virus-specific CD4+ T cell responses and enhanced antibody titers. Similar results were obtained when mice were vaccinated against HIV with adenoviral vectors encoding HIV Env and Gag-Pol in combination with various type I IFN encoding vectors. Here mainly CD4+ T cell responses were enhanced by IFNα subtypes. Conclusions Our results indicate that certain IFNα subtypes have the potential to improve the protective effect of adenovirus-based vaccines against retroviruses. This correlated with augmented virus-specific CD4+ T cell and antibody responses. Thus, co-expression of select type I IFNs may be a valuable tool for the development of anti-retroviral vaccines.

Details

Title: Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes
Authors/Creators: W. Bayer (Author/Creator)
R. Lietz (Author/Creator)
T. Ontikatze (Author/Creator)
L. Johrden (Author/Creator)
M. Tenbusch (Author/Creator)
G. Nabi (Author/Creator)
S. Schimmer (Author/Creator)
P. Groitl (Author/Creator)
H. Wolf (Author/Creator)
C.M. Berry (Author/Creator)
K. Überla (Author/Creator)
U. Dittmer (Author/Creator)
O. Wildner (Author/Creator)
Publication Details: Retrovirology, Vol.8(1)
Publisher: BioMed Central
Identifiers: 991005540932307891
Copyright: © 2011 Bayer et al
Murdoch Affiliation: School of Veterinary and Biomedical Sciences
Language: English
Resource Type: Journal article

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Metrics

170 File views/ downloads

51 Record Views

20 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.25 Molecular & Cell Biology - Cancer, Autophagy & Apoptosis; 1.25.537 c-Myc
Web Of Science research areas: Virology
ESI research areas: Microbiology